Rosiglitazone Attenuates the Severity of Hyperlipidemic Severe Acute Pancreatitis in Rats
Overview
Authors
Affiliations
Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligand regulates adipocyte differentiation and insulin sensitivity, and exerts antihyperlipidemic and anti-inflammatory effects. However, the mechanisms by which PPAR-γ ligands affect hyperlipidemia with severe acute pancreatitis (SAP) have not been fully elucidated. The present study investigated the effects of rosiglitazone, a PPAR-γ ligand, on hyperlipidemia with SAP in a rat model. The hyperlipidemia was induced with a high-fat diet and SAP was induced by the administration of sodium taurocholate (TCA). The hyperlipidemia was shown to aggravate the severity of the sodium taurocholate-induced SAP. However, rosiglitazone demonstrated significant antihyperlipidemic and anti-inflammatory effects in the rats with high-lipid diet-induced hyperlipidemia and SAP.
Long-chain fatty acids - The turning point between 'mild' and 'severe' acute pancreatitis.
Liu Q, Gu X, Liu X, Gu Y, Zhang H, Yang J Heliyon. 2024; 10(11):e31296.
PMID: 38828311 PMC: 11140623. DOI: 10.1016/j.heliyon.2024.e31296.
Ma Y, Li X, Liu Z, Xue X, Wang Y, Ma Y Mol Biol Rep. 2023; 50(10):8497-8507.
PMID: 37644373 DOI: 10.1007/s11033-023-08639-3.
Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research.
Wang L, Xu T, Wang R, Wang X, Wu D Dig Dis Sci. 2021; 67(3):761-772.
PMID: 33939144 DOI: 10.1007/s10620-021-06928-0.
Feng P, Xu Y, Tong B, Tong X, Bian Y, Zhao S Exp Ther Med. 2020; 19(2):1203-1212.
PMID: 32010290 PMC: 6966209. DOI: 10.3892/etm.2019.8324.
Rosiglitazone attenuates renal injury caused by hyperlipidemic pancreatitis.
Wang R, Yan Z, Wu X, Ji K, Wang H, Zang B Int J Clin Exp Pathol. 2015; 8(5):4332-43.
PMID: 26191125 PMC: 4502997.